Trevor J Henderson
Trevor Henderson is the Creative Services Director for the Laboratory Products Group at LabX Media Group. With over two decades of experience, he specializes in scientific and technical writing, editing, and content creation. His academic background includes training in human biology, physical anthropology, and community health. Since 2013, he has been developing content to engage and inform scientists and laboratorians.
Articles by Trevor J Henderson
| 3 min read
From vein-to-vein tracking to the plasmid bottleneck, logistics are the new efficacy endpoint
| 4 min read
Why the "make or buy" decision is no longer just about cost, but about the survival of the therapy itself
| 4 min read
How simulating the future is helping the industry abandon the "black box" of bioreactor biology
| 4 min read
How the industry is pivoting from "grams to tons" to meet the demand for population-level RNA therapeutics
| 3 min read
How targeted protein degradation is rewriting the rules of pharmacology and drugging the "undruggable"
| 4 min read
Why the "maximum tolerated dose" is obsolete for drugs that act like code
| 4 min read
From high-dose toxicity to commercial withdrawal, the path to a cure is paved with cautionary tales
| 3 min read
As the modality matures, safety signals and manufacturing hurdles force a regulatory rethink
| 4 min read
Why the "build it and they will come" model fails in rare disease, and how AI and concierge care are bridging the gap
| 4 min read
Why the "one-drug, one-target" biomarker model is obsolete in the age of living therapies
| 4 min read
As modalities shift from inert chemicals to biologically active gene therapies, developers must decide: rely on the broad sweep of standard histopathology or invest in the granular precision of mechanistic profiling.
| 4 min read
The "gold standard" has a blind spot: finding truth in the noise of clinical practice
